153P Ramucirumab safety in East Asian (EA) compared to non-EA patients: A meta-analysis of adverse events (AEs) in 6 global, randomized, double-blind, phase 3 clinical trials — Hyun Cheol Chung (2016) | RDL Network
153P Ramucirumab safety in East Asian (EA) compared to non-EA patients: A meta-analysis of adverse events (AEs) in 6 global, randomized, double-blind, phase 3 clinical trials
Hans Gelderblom, Emanuela Palmerini, Jean Yves Blay, Michiel A. J. van de Sande, Javier Martín‐Broto, Raúl Terés, M. B. Davies, Elyse Seltzer, S. Veltkamp, Gabriel Tinoco
Katarzyna Nabrdalik, Karolina Skonieczna‐Żydecka, Krzysztof Irlik, Mirela Hendel, Hanna Kwiendacz, Igor Łoniewski, Kornelia Januszkiewicz, Janusz Gumprecht, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.